adenosine has been researched along with Acute Disease in 95 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (12.63) | 18.7374 |
1990's | 25 (26.32) | 18.2507 |
2000's | 37 (38.95) | 29.6817 |
2010's | 18 (18.95) | 24.3611 |
2020's | 3 (3.16) | 2.80 |
Authors | Studies |
---|---|
Huang, QL; Jiang, W; Liu, JT; Lu, YC; Qie, HJ; Sun, HY; Tang, LJ; Wu, J; Yang, Y; Yuan, XH | 1 |
Erbas, O; Ercan, G; Yigitturk, G | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Alexeev, EE; Colgan, SP; Kao, DJ; Lanis, JM | 1 |
Dai, Y; Lei, J; Li, M; Tang, J; Xia, B; Xia, Y; Yin, G; Zhou, Y | 1 |
Bek, T; Holmgaard, K; Kringelholt, S | 1 |
Alexopoulos, D; Antoniucci, D; Bellandi, B; Capodanno, D; Capranzano, P; Migliorini, A; Parodi, G; Stavrou, K; Tamburino, C; Valenti, R; Xanthopoulou, I | 1 |
Dillinger, JG; Drouet, L; Henry, P; Saeed, A; Sideris, G; Silberman, SM; Sollier, CB; Spagnoli, V; Voicu, S | 1 |
Forman, MB; Hou, D; Jackson, EK | 1 |
Gilroy, DW; Jackson, EK; Newson, J; Rahman, F; Rajakariar, R; Sawmynaden, P; Smith, A; Yaqoob, MM | 1 |
Blackburn, MR; Schneider, DJ; Zhou, Y | 1 |
Cárdenas, A; Enjyoji, K; Robson, SC; Sun, X; Wu, Y | 1 |
Belardinelli, L; Dione, DP; Jadbabaie, F; Mekkaoui, C; Meoli, DF; Purushothaman, K; Sinusas, AJ | 1 |
Dilsizian, V | 1 |
Brown, JR; Mautone, A | 1 |
Cui, CS; Han, XM; Meng, J; Sheng, XT; Wang, QG; Xue, HM; Zhang, DZ; Zhang, P; Zhu, XY | 1 |
Hullin, R; Keller, RF; Lerch, R; Meyer, P; White, M | 1 |
Costello, P; Fink, C; Henzler, T; Ramachandra, A; Rowe, GW; Schoepf, UJ; Weininger, M | 1 |
Bettari, L; Bugatti, S; Carubelli, V; Dei Cas, L; Lazzarini, V; Lombardi, C; Metra, M | 1 |
Bramanti, P; Cuzzocrea, S; Di Paola, R; Esposito, E; Impellizzeri, D; Mazzon, E; Melani, A; Paterniti, I; Pedata, F | 1 |
Blumstein, H; Case, D; Hamilton, CA; Harper, EN; Hoekstra, JW; Hundley, WG; Hwang, W; Lefebvre, C; Miller, CD | 1 |
Keira, N; Kodama, N; Kusaba, T; Matsubara, H; Nishikawa, S; Nomura, T; Tatsumi, T; Terada, K; Urakabe, Y | 1 |
Bernard, A; Bernard, G; Canioni, D; Gugenheim, J; Rogel-Gaillard, C; Tauc, M; Yandza, T | 1 |
Dale, EA; Mitchell, GS; Nichols, NL | 1 |
Agarwal, A; Agarwal, M; Agarwal, MK; Chakrabarti, A; Glick, A; Gupta, K; Sharma, JP; Wald, DN; Yang, J; Zhang, Y | 1 |
Blaikley, S; Fitz-John, L; Paul, SP; Peevers, C | 1 |
Blackburn, MR; Karmouty-Quintana, H; Xia, Y | 1 |
Bastia, E; Bertorelli, R; Monopoli, A; Varani, K | 1 |
Karasawa, A; Katagiri, C; Kusaka, H; Mizutani, M; Nan-ya, K; Nishikawa, S; Noji, T; Sano, J; Takada, C | 1 |
Karasawa, A; Katagiri, C; Kusaka, H; Mizutani, M; Nan-ya, K; Nishikawa, S; Noji, T; Sano, J | 1 |
Danielewicz, R; Kosieradzki, M; Kuczynska, J; Kwiatkowski, A; Lisik, W; Michalak, G; Paczek, L; Piwowarska, J; Rowinski, WA; Wegrowicz-Rebandel, I | 1 |
Eriksson, PO; Hellström, S; Pais-Clemente, M; Spratley, J | 1 |
Karasawa, A; Kusaka, H; Noji, T | 1 |
Davies, DG; Fowler, JC; Gervitz, LM; Omidvar, K | 1 |
Celiński, K; Cichoz-Lach, H; Kasztelan-Szczerbińska, B; Szczerbiński, M; Słomka, M | 1 |
Ashton, KJ; Hack, B; Headrick, JP | 1 |
Gudmundsson, S; Ingimarsson, J; Oskarsson, G; Pesonen, E; Sandström, S; Werner, O | 1 |
de Cock, CC; Elkelini, M; Hanrath, P; Heussen, N; Hoffmann, R; Kamp, O; Lepper, W; Sieswerda, GT; Visser, CA; Voci, P | 1 |
Sharma, M; Teerlink, JR | 1 |
Blom, HJ; De Vriese, AS; Heil, SG; Kluijtmans, LA; Lameire, NH; Mortier, S; Van de Voorde, J | 1 |
Gudmundsson, P; Willenheimer, R; Winter, R | 1 |
Fukuda, K; Fukunaga, A; Hayashida, M | 1 |
Cronstein, BN; D'Eustachio, P; Delano, DL; Desai, A; Fernandez, P; Montesinos, MC; Wilder, T; Wiltshire, T | 1 |
Huang, JX; Lin, Z; Zhu, QH | 1 |
Enerson, BE; Floyd, E; Lawton, MP; Lin, A; Lu, B; Zhao, H | 1 |
Saeed Dar, M | 1 |
Biskup, W; Celiński, K; Cichoz-Lach, H; Czechowska, G; Korobowicz, E; Korolczuk, A; Madro, A; Prozorow-Król, B; Słomka, M | 1 |
Bittar, AE; Bittar, CM; Castro, DB; Garcia, VD; Goldani, JC; Keitel, E; Klaus, F; Meinne, MH; Seelig, DC | 1 |
Maeder, MT; Stöckli, M; Zellweger, MJ | 1 |
Khouadja, H; Mebazaa, A; Rezlan, E; Tavares, M; Vostroknoutova, I | 1 |
Greene, EL; Liang, KV; Redfield, MM; Williams, AW | 1 |
McCarty, MF | 1 |
Eldridge, FL; Kiley, JP; Millhorn, DE; Waldrop, TG | 1 |
Falletta, JM; Hershfield, MS; Kinney, TR; Koller, CA; Kredich, NM; Kurtzberg, J; Mitchell, BS | 1 |
Berne, RM; Rubio, R; Winn, HR | 1 |
Benson, GJ; Manohar, M; Parks, CM; Theodorakis, MC; Thurmon, JC; Tranquilli, WJ | 1 |
Downey, HF; Fan, WL; Gao, ZP; Mallet, RT | 1 |
Mentzer, RM; Sodhi, J; Van Wylen, DG; Wang, T | 1 |
Ho, KY; Smith, WM; Wilson, NJ | 1 |
Euler, DE; Rubboli, A; Sobotka, PA | 1 |
Albes, JM; Haverich, A; Rohde, R | 1 |
Guignard, JP; Huet, F; John, E; Semama, D | 1 |
Marshall, JM; Skinner, MR | 1 |
Bauer, AJ | 1 |
Kamen, BA; Quinn, CT | 1 |
Langan, MN | 1 |
Belch, AR; Gati, WP; Larratt, LM; Paterson, AR; Turner, AR | 1 |
Sollevi, A | 1 |
Nekooeian, AA; Tabrizchi, R | 1 |
Castaño, HH; Dec, GW; Dinsmore, RE; Fifer, MA; Mathier, MA; Miyamoto, MI; Palacios, IF; Rose, GA; Semigran, MJ | 1 |
Marshall, JM | 2 |
Acaroğlu, E; Akpek, EA; Alanay, A; Bulutçu, E; Kilinç, K; Korkusuz, P; Ors, U | 1 |
Hancock, EW | 1 |
Anthopoulos, LP; Antonelis, IP; Filippatos, G; Houssianakou, IK; Kardaras, F; Kranidis, AI; Patsilinakos, SP; Sioras, E; Tsiotika, T; Zamanis, NI | 1 |
Aranda, M; Bradford, KK; Pearl, RG | 1 |
Tuomennoro, J; Vornanen, M | 1 |
de Fabro, SP; Enders, J; Fernández, AR; Fretes, RE; Paglini, P | 1 |
Liu, XJ; Reid, A; Sawynok, J | 1 |
Gouyon, JB; Guignard, JP; Justrabo, E; Prévot, A; Semama, DS; Tendron, A | 1 |
Fujita, M; Ito, H; Kohno, Y; Masamune, A; Satoh, A; Satoh, K; Shimosegawa, T; Toyota, T | 1 |
Anderlini, P; Andersson, BS; Andreeff, M; Braunschweig, I; Bruton, J; Champlin, R; Claxton, D; Cohen, A; Davis, M; Donato, M; Gajewski, J; Giralt, S; Ippolitti, C; Khouri, I; Kornblau, S; Molldrem, J; Przepiorka, D; Thall, PF; Ueno, NT; Wang, X | 1 |
Arntz, E; Boemke, W; Höhne, C; Kaczmarczyk, G; Krebs, MO | 1 |
Domej, W; Röggla, G; Röggla, M | 1 |
Chrysostomakis, SI; Igoumenidis, NE; Kalebubas, MD; Kanoupakis, EM; Kochiadakis, GE; Simantirakis, EN; Skalidis, EI; Vardas, PE | 1 |
Agnoli, A; Arrigoni, E; Benzi, G; Villa, RF | 1 |
Eliseev, VV; Katkov, VF; Nagornev, SN; Poltavchenko, GM | 1 |
Dellsperger, KC; Eastham, CL; Janzen, DL; Marcus, ML | 1 |
Akhtar, M; DiMarco, JP; Govier, WC; McGovern, B; Miles, W; Milstein, S; Platia, E; Scheinman, MM; Sharma, AD | 1 |
Cartner, LA; Holliss, DG; Humphrey, SM | 1 |
Gewirtz, H; Most, AS; Olsson, RA | 1 |
Vaisrub, S | 1 |
Bloom, GE | 1 |
Heggtveit, HA; Mommaerts, WF; Scheuer, J | 1 |
Gakis, C; Giusti, G | 1 |
19 review(s) available for adenosine and Acute Disease
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Tissue metabolism and the inflammatory bowel diseases.
Topics: Acute Disease; Adenosine; Animals; Disease Susceptibility; Energy Metabolism; Gastrointestinal Microbiome; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Inflammatory Bowel Diseases; Intestinal Mucosa; Organ Specificity; Tryptophan | 2017 |
Adenosine signaling and the regulation of chronic lung disease.
Topics: Acute Disease; Adenosine; Adenosine Deaminase; Animals; Chronic Disease; Disease Models, Animal; Humans; Lung Diseases, Interstitial; Lung Diseases, Obstructive; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction | 2009 |
Contrast-induced nephropathy in patients undergoing elective and urgent procedures.
Topics: Acetylcysteine; Acute Disease; Acute Kidney Injury; Adenosine; Ascorbic Acid; Contrast Media; Elective Surgical Procedures; Emergency Treatment; Free Radical Scavengers; General Surgery; Glomerular Filtration Rate; Humans; Hydrotherapy; Preoperative Care; Renal Dialysis; Risk Assessment; Sodium Bicarbonate | 2010 |
[What is new in the medical management of acute heart failure?].
Topics: Acute Disease; Adenosine; Algorithms; Cardiotonic Agents; Diuretics; Drug Therapy, Combination; Etiocholanolone; Heart Failure; Hemodiafiltration; Humans; Oxygen Inhalation Therapy; Practice Guidelines as Topic; Prognosis; Relaxin; Risk Factors; Treatment Outcome; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins | 2010 |
Can we prevent or treat renal dysfunction in acute heart failure?
Topics: Acute Disease; Adenosine; Biomarkers; Cardiotonic Agents; Diuretics; Dopamine; Heart Failure; Humans; Kidney; Kidney Diseases; Mineralocorticoid Receptor Antagonists; Prognosis; Vasodilator Agents; Vasopressins | 2012 |
Adenosine signaling during acute and chronic disease states.
Topics: Acute Disease; Adenosine; Animals; Chronic Disease; Humans; Signal Transduction | 2013 |
[Pharmacological study on the effects of the adenosine uptake inhibitor KF24345 on inflammatory diseases].
Topics: Acute Disease; Adenosine; Animals; Depression, Chemical; Erythrocytes; Glomerulonephritis; Humans; Inflammation; Leukopenia; Lipopolysaccharides; Mice; Neurotransmitter Uptake Inhibitors; Pancreatitis; Pyrimidinones; Quinazolines; Tumor Necrosis Factor-alpha | 2003 |
Acute adenosinergic cardioprotection in ischemic-reperfused hearts.
Topics: Acute Disease; Adenosine; Animals; Humans; Myocardial Reperfusion Injury; Receptors, Purinergic P1 | 2003 |
A rational approach for the treatment of acute heart failure: current strategies and future options.
Topics: Acute Disease; Adenosine; Cardiotonic Agents; Catheterization, Swan-Ganz; Dobutamine; Drug Therapy; Endothelins; Forecasting; Heart Failure; Humans; Milrinone; Natriuretic Peptide, Brain; Vasopressins | 2004 |
Clinical application of adenosine and ATP for pain control.
Topics: Acute Disease; Adenosine; Adenosine Triphosphate; Animals; Chronic Disease; Humans; Injections, Intravenous; Injections, Spinal; Pain; Pain, Postoperative | 2005 |
New pharmacologic therapies for acute heart failure.
Topics: Acute Disease; Adenosine; Adenosine Triphosphatases; Antidiuretic Hormone Receptor Antagonists; Cardiac Myosins; Cardiotonic Agents; Endothelin Receptor Antagonists; Heart Failure; Humans; Hydrazones; Natriuretic Peptides; Pyridazines; Simendan | 2008 |
Acute decompensated heart failure and the cardiorenal syndrome.
Topics: Acute Disease; Adenosine; Cardiotonic Agents; Dopamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Renal Insufficiency; Risk Factors; Sodium Potassium Chloride Symporter Inhibitors; Ultrafiltration; Vasopressins | 2008 |
Acute renal failure.
Topics: Acute Disease; Acute Kidney Injury; Adenosine; Age Factors; Angiotensin II; Animals; Animals, Newborn; Blood Flow Velocity; Calcium Channels; Disease Models, Animal; Endothelins; Free Radicals; Glomerular Filtration Rate; Humans; Hypoxia; Infant, Newborn; Rabbits; Reactive Oxygen Species; Renal Circulation; Risk Factors | 1993 |
Transplantation-induced injuries of the intestinal muscularis and its innervation: from preservation to chronic rejection.
Topics: Acute Disease; Adenosine; Allopurinol; Animals; Chronic Disease; Glutathione; Graft Rejection; Humans; Insulin; Intestine, Small; Organ Preservation; Organ Preservation Solutions; Raffinose; Reperfusion Injury; Transplantation, Homologous | 1996 |
A biochemical perspective of methotrexate neurotoxicity with insight on nonfolate rescue modalities.
Topics: Acute Disease; Adenosine; Biopterins; Chronic Disease; Folic Acid Antagonists; Homocysteine; Humans; Methotrexate; Nervous System Diseases; Nucleic Acid Synthesis Inhibitors | 1996 |
Adenosine for pain control.
Topics: Acute Disease; Adenosine; Analgesics; Analgesics, Opioid; Animals; Central Nervous System; Chronic Disease; Disease Models, Animal; Hot Temperature; Humans; Infusions, Intravenous; Injections, Intravenous; Injections, Spinal; Neurons, Afferent; Nociceptors; Pain; Peripheral Nerves; Pressure; Receptors, Cell Surface; Rodentia; Spinal Cord; Touch | 1997 |
Chemoreceptors and cardiovascular control in acute and chronic systemic hypoxia.
Topics: Acute Disease; Adenosine; Cardiovascular Physiological Phenomena; Chemoreceptor Cells; Chronic Disease; Humans; Hypoxia; Muscle, Skeletal; Norepinephrine; Oxygen; Vasoconstriction; Vasodilation | 1998 |
Roles of adenosine and nitric oxide in skeletal muscle in acute and chronic hypoxia.
Topics: Acute Disease; Adenosine; Animals; Chronic Disease; Humans; Hypoxia; Muscle, Skeletal; Nitric Oxide | 2001 |
8 trial(s) available for adenosine and Acute Disease
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects and severe pulmonary arterial hypertension.
Topics: Acute Disease; Adenosine; Administration, Inhalation; Adolescent; Adult; Child; Heart Defects, Congenital; Hemodynamics; Humans; Hypertension, Pulmonary; Iloprost; Infusions, Intravenous; Severity of Illness Index; Young Adult | 2011 |
Adenosine-stress dynamic real-time myocardial perfusion CT and adenosine-stress first-pass dual-energy myocardial perfusion CT for the assessment of acute chest pain: initial results.
Topics: Acute Disease; Adenosine; Aged; Chest Pain; Computer Systems; Coronary Angiography; Exercise Test; Humans; Middle Aged; Myocardial Perfusion Imaging; Pilot Projects; Radiography, Dual-Energy Scanned Projection; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Vasodilator Agents | 2012 |
Stress CMR imaging observation unit in the emergency department reduces 1-year medical care costs in patients with acute chest pain: a randomized study for comparison with inpatient care.
Topics: Acute Disease; Adenosine; Chest Pain; Cost Savings; Delivery of Health Care; Dobutamine; Drug Costs; Emergency Service, Hospital; Female; Heart Diseases; Hospital Costs; Humans; Inpatients; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Models, Economic; North Carolina; Patient Admission; Patient Discharge; Predictive Value of Tests; Time Factors | 2011 |
Kidney transplantation with Belzer or Custodiol solution: a randomized prospective study.
Topics: Acute Disease; Adenosine; Allopurinol; Female; Glucose; Glutathione; Graft Rejection; Humans; Immunosuppressive Agents; Insulin; Kidney Transplantation; Length of Stay; Male; Mannitol; Organ Preservation Solutions; Pancreas Transplantation; Postoperative Complications; Potassium Chloride; Procaine; Prospective Studies; Raffinose; Survival Analysis | 2007 |
Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.
Topics: Acute Disease; Adenosine; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cladribine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Survival Rate; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2001 |
Does theophylline really improve acute mountain sickness?
Topics: Acute Disease; Adenosine; Adult; Altitude Sickness; Cross-Over Studies; Double-Blind Method; Humans; Male; Remission Induction; Theophylline | 2001 |
Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.
Topics: Acute Disease; Adenosine; Adult; Aged; Clinical Protocols; Confounding Factors, Epidemiologic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Verapamil | 1990 |
69 other study(ies) available for adenosine and Acute Disease
Article | Year |
---|---|
Genome-wide map of N
Topics: Acute Disease; Adenosine; Animals; Mice; Mice, Inbred C57BL; MicroRNAs; Pancreatitis; RNA, Circular | 2021 |
Therapeutic effect of adenosine on experimentally induced acute ulcerative colitis model in rats.
Topics: Acetic Acid; Acute Disease; Adenosine; Animals; Anti-Inflammatory Agents; C-Reactive Protein; Colitis, Ulcerative; Colon; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Male; Malondialdehyde; NF-kappa B; Rats, Sprague-Dawley; Rectum; Reference Values; Reproducibility of Results; Serum Amyloid P-Component; Thiobarbituric Acid Reactive Substances; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2020 |
Acute rejection after kidney transplantation promotes graft fibrosis with elevated adenosine level in rat.
Topics: Acute Disease; Adenosine; Allografts; Animals; Collagen; Fibrosis; Graft Rejection; Isografts; Kidney; Kidney Transplantation; Rats; Rats, Sprague-Dawley; Rats, Wistar | 2017 |
Relaxation of porcine retinal arterioles during acute hypoxia in vitro depends on prostaglandin and NO synthesis in the perivascular retina.
Topics: Acute Disease; Adenosine; Animals; Arterioles; Glutamic Acid; Hyperoxia; Hypoxia; In Vitro Techniques; Myography; Nitric Oxide; Oxygen; Prostaglandins; Retinal Vessels; Swine; Vasodilation | 2013 |
Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.
Topics: Acute Disease; Adenosine; Age Factors; Aged; Analgesics, Opioid; Drug Interactions; Electrocardiography; Female; Humans; Male; Middle Aged; Morphine; Myocardial Infarction; Percutaneous Coronary Intervention; Piperazines; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Thiophenes; Ticagrelor | 2015 |
High platelet reactivity on aspirin in patients with acute ST elevation myocardial infarction.
Topics: Acute Disease; Adenosine; Aspirin; Blood Platelets; Brain Ischemia; Cardiovascular Diseases; Clopidogrel; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Survival Analysis; Ticagrelor; Ticlopidine | 2016 |
Treating acute "no-reflow" with intracoronary adenosine in 4 patients during percutaneous coronary intervention.
Topics: Acute Disease; Adenosine; Aged; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Graft Survival; Hemodynamics; Humans; Male; Middle Aged; Perfusion; Vasodilator Agents | 2008 |
Nonresolving inflammation in gp91phox-/- mice, a model of human chronic granulomatous disease, has lower adenosine and cyclic adenosine 5'-monophosphate.
Topics: Acute Disease; Adenosine; Animals; Cells, Cultured; Cyclic AMP; Disease Models, Animal; Granulomatous Disease, Chronic; Humans; Inflammation; Inflammation Mediators; Leukopenia; Membrane Glycoproteins; Mice; Mice, Knockout; NADPH Oxidase 2; NADPH Oxidases; Peritonitis | 2009 |
Vascular stasis, intestinal hemorrhage, and heightened vascular permeability complicate acute portal hypertension in cd39-null mice.
Topics: Acute Disease; Adenosine; Adenosine Triphosphate; Animals; Antigens, CD; Apyrase; Capillary Permeability; Constriction, Pathologic; Disease Models, Animal; Gastrointestinal Hemorrhage; Hypertension, Portal; Ligation; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Nitric Oxide; Portal Pressure; Portal Vein; Splanchnic Circulation; Time Factors | 2009 |
Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
Topics: Acute Disease; Adenosine; Adenosine A2 Receptor Agonists; Animals; Blood Flow Velocity; Chronic Disease; Coronary Circulation; Coronary Stenosis; Disease Models, Animal; Dogs; Hyperemia; Infusions, Intravenous; Injections, Intravenous; Metabolic Clearance Rate; Myocardial Perfusion Imaging; Myocardium; Predictive Value of Tests; Purines; Pyrazoles; Radiopharmaceuticals; Receptor, Adenosine A2A; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2009 |
Connectivity of radiotracers to vasodilators is thallium the missing link?
Topics: Acute Disease; Adenosine; Adenosine A2 Receptor Agonists; Animals; Blood Flow Velocity; Chronic Disease; Coronary Circulation; Coronary Stenosis; Dogs; Humans; Hyperemia; Infusions, Intravenous; Injections, Intravenous; Metabolic Clearance Rate; Myocardial Perfusion Imaging; Myocardium; Predictive Value of Tests; Purines; Pyrazoles; Radiopharmaceuticals; Receptor, Adenosine A2A; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2009 |
CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation.
Topics: Acute Disease; Adenosine; Adenosine A2 Receptor Agonists; Animals; bcl-2-Associated X Protein; Carrageenan; Cytokines; Enzyme Activation; Fas Ligand Protein; Gene Expression Regulation, Enzymologic; I-kappa B Proteins; Intercellular Adhesion Molecule-1; Lipid Peroxidation; Male; Mice; NF-KappaB Inhibitor alpha; Nitrates; Nitric Oxide Synthase Type II; Nitrites; P-Selectin; Peroxidase; Phenethylamines; Pleurisy; Pneumonia; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Receptor, Adenosine A2A; Transcription Factor RelA; Tyrosine | 2011 |
Clinical characteristics of silent myocardial ischemia diagnosed with adenosine stress 99mTc-tetrofosmin myocardial scintigraphy in Japanese patients with acute cerebral infarction.
Topics: Acute Disease; Adenosine; Aged; Cerebral Infarction; Coronary Angiography; Diagnosis, Differential; Exercise Test; Female; Follow-Up Studies; Humans; Incidence; Japan; Male; Myocardial Ischemia; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2013 |
Effect of polyethylene glycol in pig intestinal allotransplantation without immunosuppression.
Topics: Acute Disease; Adenosine; Allopurinol; Animals; Apoptosis; Caspase 3; Female; Glutathione; Graft Rejection; Graft Survival; Immunosuppression Therapy; Insulin; Intestinal Mucosa; Intestine, Small; Organ Preservation Solutions; Polyethylene Glycols; Raffinose; Reperfusion Injury; Sus scrofa; Transplantation, Homologous | 2012 |
Severe acute intermittent hypoxia elicits phrenic long-term facilitation by a novel adenosine-dependent mechanism.
Topics: Acute Disease; Adenosine; Adenosine A2 Receptor Antagonists; Animals; Blood Pressure; Carbon Dioxide; Disease Models, Animal; Hypoxia; Injections, Spinal; Lung; Male; Neuronal Plasticity; Oxygen; Phrenic Nerve; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Serotonin, 5-HT2; Respiration; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Severity of Illness Index; Time Factors | 2012 |
ATP depletion triggers acute myeloid leukemia differentiation through an ATR/Chk1 protein-dependent and p53 protein-independent pathway.
Topics: Acute Disease; Adenosine; Adenosine Triphosphate; Antibiotics, Antineoplastic; Ataxia Telangiectasia Mutated Proteins; Blotting, Western; Caffeine; Cell Cycle Proteins; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Comet Assay; DNA Damage; Doxorubicin; HEK293 Cells; Humans; Leukemia, Myeloid; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Signal Transduction; Staurosporine; Thioinosine; Tumor Suppressor Protein p53 | 2012 |
Acute supraventricular tachycardia in children.
Topics: Acute Disease; Adenosine; Adolescent; Algorithms; Anti-Arrhythmia Agents; Child; Child, Preschool; Electrocardiography; Emergencies; Humans; Infant; Male; Tachycardia, Supraventricular; Wolff-Parkinson-White Syndrome | 2012 |
Effects of A(1) and A(2A) adenosine receptor ligands in mouse acute models of pain.
Topics: Acute Disease; Adenosine; Animals; Behavior, Animal; Ligands; Mice; Nociceptors; Pain; Pain Measurement; Pyrimidines; Receptor, Adenosine A2A; Receptors, Purinergic P1; Triazoles | 2002 |
KF24345, an adenosine uptake inhibitor, ameliorates the severity and mortality of lethal acute pancreatitis via endogenous adenosine in mice.
Topics: Acute Disease; Adenosine; Amylases; Animals; Choline Deficiency; Diet; Female; L-Lactate Dehydrogenase; Mice; Neurotransmitter Uptake Inhibitors; Organ Size; Pancreas; Pancreatitis; Pyrimidinones; Quinazolines; Time Factors; Tumor Necrosis Factor-alpha | 2002 |
Adenosine uptake inhibition ameliorates cerulein-induced acute pancreatitis in mice.
Topics: Acute Disease; Adenosine; Amylases; Animals; Biological Transport; Ceruletide; Dipyridamole; Female; Lipase; Mice; Mice, Inbred BALB C; Models, Chemical; Pancreatitis; Piperazines; Pyrimidinones; Quinazolines; Theophylline | 2002 |
Prognostic significance of free radicals: mediated injury occurring in the kidney donor.
Topics: Acute Disease; Adenosine; Adolescent; Adult; Aged; Allopurinol; Antioxidants; Brain Death; Creatinine; Female; Free Radicals; Glutathione; Graft Rejection; Humans; Insulin; Kidney; Kidney Diseases; Kidney Transplantation; Male; Malondialdehyde; Middle Aged; Organ Preservation Solutions; Prognosis; Prospective Studies; Raffinose; Time Factors; Tissue Donors | 2003 |
Tympanic membrane vessel revisited: a study in an animal model.
Topics: Acute Disease; Adenosine; Animals; Antigens; Coagulants; Disease Models, Animal; Immunohistochemistry; Isoantibodies; Male; Neovascularization, Pathologic; Otitis Media, Suppurative; Rats; Rats, Sprague-Dawley; Streptococcal Infections; Streptococcus pneumoniae; Time Factors; Tympanic Membrane; Vasodilator Agents; von Willebrand Factor | 2003 |
The effect of acute hypoxemia and hypotension on adenosine-mediated depression of evoked hippocampal synaptic transmission.
Topics: Acute Disease; Adenosine; Animals; Blood Flow Velocity; Blood Gas Analysis; Blood Pressure; Carotid Artery, Common; Cerebrovascular Circulation; Excitatory Postsynaptic Potentials; Hippocampus; Hypotension; Hypoxia; Male; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Synaptic Transmission; Theophylline; Vasoconstrictor Agents; Vasodilator Agents | 2003 |
Influence of adenosine receptors on the development of caerulein-induced acute pancreatitis.
Topics: Acute Disease; Adenosine; Animals; Ceruletide; Male; Pancreatitis; Rats; Rats, Wistar; Receptors, Purinergic P1 | 2002 |
Coronary flow reserve in the newborn lamb: an intracoronary Doppler guide wire study.
Topics: Acute Disease; Adenosine; Animals; Animals, Newborn; Carbon Dioxide; Coronary Circulation; Disease Models, Animal; Female; Hypoxia; Male; Oxygen; Sheep; Ultrasonography, Doppler; Ultrasonography, Interventional; Vasodilator Agents | 2004 |
Impact of flow level on coronary flow velocity pattern. A doppler flow study in patients with first acute myocardial infarction.
Topics: Acute Disease; Adenosine; Angioplasty, Balloon, Coronary; Blood Flow Velocity; Chi-Square Distribution; Cohort Studies; Contrast Media; Coronary Circulation; Echocardiography, Doppler; Female; Fluorocarbons; Follow-Up Studies; Humans; Hyperemia; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Stents; Vasodilator Agents; Ventricular Function, Left | 2004 |
Endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia.
Topics: Acetylcholine; Acute Disease; Adenosine; Animals; Biological Factors; Chronic Disease; Cyclooxygenase Inhibitors; Endothelium, Vascular; Female; Hyperhomocysteinemia; Indomethacin; Methionine; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitroso Compounds; Oxidation-Reduction; Pinacidil; Potassium Channels; Rats; Rats, Wistar; Renal Circulation; Vasodilation; Vitamin B Complex; Vitamin B Deficiency | 2004 |
Real-time perfusion adenosine stress echocardiography in the coronary care unit: a feasible bedside tool for predicting coronary artery stenosis in patients with acute coronary syndrome.
Topics: Acute Disease; Adenosine; Aged; Aged, 80 and over; Coronary Care Units; Coronary Stenosis; Echocardiography, Stress; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Point-of-Care Systems; Predictive Value of Tests; Sensitivity and Specificity | 2005 |
Genetically based resistance to the antiinflammatory effects of methotrexate in the air-pouch model of acute inflammation.
Topics: Acute Disease; Adenosine; Air; Animals; Anti-Inflammatory Agents; Carrageenan; Chromosome Mapping; Disease Models, Animal; Drug Resistance; Exudates and Transudates; Inbreeding; Inflammation; Injections, Subcutaneous; Methotrexate; Mice; Mice, Inbred Strains; Osmolar Concentration; Phenotype; Quantitative Trait Loci | 2005 |
[Therapeutic efficacy of N6-cyclopentyladenosine against acute dichlorvos poisoning].
Topics: Acetylcholine; Acute Disease; Adenosine; Animals; Cholinesterases; Dichlorvos; Insecticides; Male; Mice; Mice, Inbred Strains; Poisoning; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley | 2005 |
Acute drug-induced vascular injury in beagle dogs: pathology and correlating genomic expression.
Topics: Acute Disease; Adenosine; Administration, Oral; Animals; Biomarkers; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Gene Expression; Gene Expression Profiling; Genomics; Male; Oligonucleotide Array Sequence Analysis; Purinergic P1 Receptor Agonists; Toxicity Tests; Vasculitis | 2006 |
Co-modulation of acute ethanol-induced motor impairment by mouse cerebellar adenosinergic A1 and GABA(A) receptor systems.
Topics: Acute Disease; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Alcohol-Induced Disorders, Nervous System; Animals; Central Nervous System Depressants; Cerebellar Ataxia; Cerebellum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Male; Mice; Mice, Inbred ICR; Presynaptic Terminals; Receptor, Adenosine A1; Receptors, GABA-A; Synaptic Transmission; Xanthines | 2006 |
The role of adenosine A2a receptors in experimental acute pancreatitis.
Topics: Acute Disease; Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Amylases; Animals; Disease Models, Animal; Immunohistochemistry; Lipase; Male; Pancreas; Pancreatitis; Phenethylamines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Taurocholic Acid; Triazines; Triazoles | 2006 |
Adenosine-induced severe acute respiratory distress in chronic obstructive pulmonary disease: a myth?
Topics: Acute Disease; Adenosine; Aged; Female; Humans; Magnetic Resonance Angiography; Pulmonary Disease, Chronic Obstructive; Respiratory Distress Syndrome | 2007 |
Management of acute myocardial infarction with natural physiological agents.
Topics: Acute Disease; Adenosine; Animals; Carnitine; Collateral Circulation; Dipyridamole; Dogs; Epoprostenol; Glucose; Humans; Insulin; Isoproterenol; Magnesium; Methoxamine; Myocardial Infarction; Nitroglycerin; Potassium; Vasodilator Agents | 1983 |
Prolonged inhibition of respiration following acute hypoxia in glomectomized cats.
Topics: Acute Disease; Adenosine; Animals; Carotid Body; Cats; Denervation; Extracellular Space; Hydrogen-Ion Concentration; Hypoxia; Medulla Oblongata; Phrenic Nerve; Respiration; Theophylline | 1984 |
S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.
Topics: Acute Disease; Adenosine; Adult; Coformycin; Deoxyadenosines; Drug Resistance; Drug Therapy, Combination; Erythrocytes; Homocysteine; Humans; Leukemia, Lymphoid; Lymphocytes; Male; Pentostatin; Ribonucleosides; S-Adenosylhomocysteine; Time Factors; Vidarabine | 1983 |
Brain adenosine concentration during hypoxia in rats.
Topics: Acute Disease; Adenine Nucleotides; Adenosine; Animals; Arteries; Blood; Brain Chemistry; Carbon Dioxide; Freezing; Hypoxia, Brain; Lactates; Lactic Acid; Oxygen; Partial Pressure; Phosphocreatine; Rats; Time Factors | 1981 |
Regional myocardial blood flow and coronary vasodilator reserve during acute right ventricular failure due to pressure overload in swine.
Topics: Acute Disease; Adenosine; Animals; Blood Pressure; Constriction, Pathologic; Coronary Circulation; Female; Heart; Heart Diseases; Heart Ventricles; Male; Regional Blood Flow; Swine; Vasodilation | 1981 |
Does interstitial adenosine mediate acute hibernation of guinea pig myocardium?
Topics: 5'-Nucleotidase; Acute Disease; Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cytosol; Guinea Pigs; Heart; Inosine; Lactates; Lactic Acid; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Stunning; Myocardium; Phosphorylation; Theophylline | 1995 |
Changes in interstitial adenosine during hypoxia: relationship to oxygen supply:demand imbalance, and effects of adenosine deaminase.
Topics: Acute Disease; Adenosine; Adenosine Deaminase; Animals; Coronary Circulation; Dogs; Extracellular Space; Female; Hypoxanthines; Hypoxia; Inosine; Male; Myocardium; Oxygen; Xanthines | 1994 |
Acute treatment of paroxysmal tachycardia by adenosine.
Topics: Acute Disease; Adenosine; Adolescent; Adult; Aged; Aged, 80 and over; Child; Contraindications; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Tachycardia, Paroxysmal; Verapamil | 1994 |
Effect of acute edema on left ventricular function and coronary vascular resistance in the isolated rat heart.
Topics: Acute Disease; Adenosine; Animals; Body Water; Coronary Circulation; Diastole; Edema, Cardiac; Heart; In Vitro Techniques; Male; Myocardium; Perfusion; Pressure; Rats; Rats, Sprague-Dawley; Regression Analysis; Time Factors; Vascular Resistance; Ventricular Function, Left | 1994 |
Protection of the right ventricular myocardium during acute right heart failure from pulmonary hypertension.
Topics: Acute Disease; Adenosine; Allopurinol; Animals; Cardioplegic Solutions; Disease Models, Animal; Embolectomy; Evaluation Studies as Topic; Extracorporeal Circulation; Glucose; Glutathione; Heart Arrest, Induced; Heart Failure; Hypertension, Pulmonary; Insulin; Male; Myocardial Reperfusion Injury; Organ Preservation Solutions; Pulmonary Embolism; Raffinose; Rats; Rats, Inbred Lew; Tromethamine; Ventricular Function, Right | 1994 |
Studies on the roles of ATP, adenosine and nitric oxide in mediating muscle vasodilatation induced in the rat by acute systemic hypoxia.
Topics: 5'-Nucleotidase; Acute Disease; Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Enzyme Inhibitors; Hypoxia; Male; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxygen Consumption; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Regional Blood Flow; Theophylline; Vasodilation | 1996 |
The acute treatment of supraventricular tachycardia.
Topics: Acute Disease; Adenosine; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Calcium Channel Blockers; Catheter Ablation; Digoxin; Diltiazem; Electrocardiography; Humans; Tachycardia, Supraventricular | 1997 |
Sensitivity of acute leukemia cells to cytarabine is a correlate of cellular es nucleoside transporter site content measured by flow cytometry with SAENTA-fluorescein.
Topics: Acute Disease; Adenosine; Affinity Labels; Antimetabolites, Antineoplastic; Carrier Proteins; Cell Death; Cytarabine; Flow Cytometry; Fluorescein; Fluoresceins; Humans; Leukemia; Nucleosides; Thionucleosides; Tumor Cells, Cultured | 1997 |
Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat.
Topics: Acute Disease; Adenosine; Anesthesia; Animals; Antihypertensive Agents; Blood Pressure; Cardiac Output; Heart Failure; Heart Rate; Male; Microspheres; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Vascular Resistance; Ventricular Function, Left | 1998 |
Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy.
Topics: Acetylcholine; Acute Disease; Adenosine; Adolescent; Adult; Aged; Cardiac Catheterization; Cardiomyopathy, Dilated; Coronary Circulation; Endothelium, Vascular; Female; Heart Failure; Humans; Infusions, Intra-Arterial; Laser-Doppler Flowmetry; Male; Middle Aged; Stroke Volume; Systole; Vasodilator Agents; Ventricular Function, Left | 1998 |
A study of adenosine treatment in experimental acute spinal cord injury. Effect on arachidonic acid metabolites.
Topics: Acute Disease; Adenosine; Animals; Arachidonic Acid; Dinoprostone; Disease Models, Animal; Laminectomy; Leukotriene C4; Lipid Peroxidation; Male; Myelin Sheath; Nerve Compression Syndromes; Random Allocation; Rats; Rats, Wistar; Spinal Cord; Spinal Cord Injuries; Vasodilator Agents | 1999 |
Sudden tachycardia at rest in a 39-year-old man.
Topics: Acute Disease; Adenosine; Adult; Anti-Arrhythmia Agents; Electrocardiography; Emergency Treatment; Heart Valve Diseases; Humans; Male; Rest; Tachycardia, Supraventricular | 1999 |
Detection of coronary artery disease in patients with severe aortic stenosis with noninvasive methods.
Topics: Acute Disease; Adenosine; Adult; Aged; Aged, 80 and over; Aortic Valve Stenosis; Cardiac Catheterization; Coronary Angiography; Coronary Disease; Echocardiography; Exercise Test; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1999 |
Combined therapy with inhaled nitric oxide and intravenous vasodilators during acute and chronic experimental pulmonary hypertension.
Topics: Acute Disease; Adenosine; Administration, Inhalation; Animals; Chronic Disease; Drug Therapy, Combination; Epoprostenol; Hypertension, Pulmonary; Injections, Intravenous; Male; Nitric Oxide; Nitroprusside; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1999 |
Effects of acute anoxia on heart function in crucian carp: importance of cholinergic and purinergic control.
Topics: Acute Disease; Adenosine; Animals; Atrial Function; Carbachol; Cardiotonic Agents; Cardiovascular Agents; Carps; Electrophysiology; Heart Rate; Hypoxia; In Vitro Techniques; Muscarine; Muscarinic Agonists; Myocardial Contraction; Purines; Sodium Cyanide; Ventricular Function | 1999 |
Trypanosoma cruzi: increased 5'-nucleotidase activity associated with dysfunction of adrenergic receptors in acutely infected albino Swiss mice.
Topics: 5'-Nucleotidase; Acute Disease; Adenosine; Animals; Chagas Disease; Densitometry; Heart Ventricles; Immunohistochemistry; Mice; Microscopy, Electron; Myocardium; Receptors, Adrenergic, beta; Trypanosoma cruzi | 1999 |
Acute paw oedema induced by local injection of adenosine A(1), A(2) and A(3) receptor agonists.
Topics: Acute Disease; Adenosine; Adenosine Deaminase Inhibitors; Adenosine Kinase; Animals; Caffeine; Drug Interactions; Edema; Enzyme Inhibitors; Histamine H1 Antagonists; Male; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrilamine; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A3 | 1999 |
Endothelin, angiotensin II and adenosine in acute cyclosporine A nephrotoxicity.
Topics: Acute Disease; Adenosine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cyclosporine; Endothelins; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Perindopril; Rabbits; Renal Circulation; Theophylline; Vascular Resistance; Water | 2000 |
Activation of adenosine A1-receptor pathway induces edema formation in the pancreas of rats.
Topics: Acute Disease; Adenosine; Amylases; Animals; Ceruletide; Edema; Leukocytes; Male; Pancreas; Pancreatic Diseases; Pancreatitis; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyridines; Rats; Rats, Wistar; Receptor, Adenosine A3; Receptors, Purinergic P1; Taurocholic Acid | 2000 |
Evidence that the renin decrease during hypoxia is adenosine mediated in conscious dogs.
Topics: Acute Disease; Adenosine; Aldosterone; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Carbon Dioxide; Consciousness; Diet, Sodium-Restricted; Dogs; Female; Heart Rate; Hemodynamics; Hypoxia; Oxygen; Partial Pressure; Potassium; Purinergic P1 Receptor Antagonists; Renin; Renin-Angiotensin System; Theophylline | 2001 |
Effect of acute atrial fibrillation on phasic coronary blood flow pattern and flow reserve in humans.
Topics: Acute Disease; Adenosine; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Blood Flow Velocity; Blood Pressure; Coronary Circulation; Female; Heart Atria; Heart Block; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Statistics as Topic; Vascular Resistance | 2002 |
[Cerebral energy status and the acute hyperammoniaenia syndrome: interference of S-adenosyl-L-methionine and adenosine].
Topics: Acute Disease; Adenosine; Ammonia; Animals; Biotransformation; Brain; Dogs; Energy Metabolism; Glycolysis; Membrane Potentials; Premedication; Rest; S-Adenosylmethionine; Syndrome | 1978 |
[New adenosine derivatives as agents to prevent postischemic disorders].
Topics: Acute Disease; Adenosine; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hypoxia; Ischemia; Liver; Male; Rats | 1991 |
Effects of acute coronary artery occlusion on the coronary microcirculation.
Topics: Acute Disease; Adenosine; Animals; Constriction, Pathologic; Coronary Circulation; Coronary Disease; Dogs; Edetic Acid; Female; Gases; Hemodynamics; Injections, Intravenous; Male; Microcirculation; Vasodilation | 1990 |
The influence of inhibitors of the ATP degradative pathway on recovery of function and high energy phosphate after transient ischemia in the rat heart.
Topics: 5'-Nucleotidase; Acute Disease; Adenine; Adenine Nucleotides; Adenosine; Adenosine Deaminase Inhibitors; Adenosine Diphosphate; Adenosine Triphosphate; Adenylate Kinase; Animals; Coronary Circulation; Coronary Disease; Dinucleoside Phosphates; Male; Nucleotidases; Rats; Rats, Inbred Strains; Thioinosine | 1986 |
Role of adenosine in mediating the coronary vasodilative response to acute hypoxia.
Topics: Acute Disease; Adenosine; Adenosine Deaminase; Animals; Coronary Circulation; Coronary Vessels; Hemodynamics; Hypoxia; Lactates; Lactic Acid; Myocardium; Oxygen; Swine; Vasodilation | 1987 |
Editorial: Accomplices in crime.
Topics: Acute Disease; Adenosine; Animals; Collateral Circulation; Coronary Circulation; Dogs; Drug Synergism; Electrocardiography; Heart; Humans; Isoproterenol; Lactates; Myocardial Infarction; Stimulation, Chemical; Subclavian Steal Syndrome; Vasodilator Agents | 1974 |
Leukocyte adenosine deaminase phenotypes in acute leukemia.
Topics: Acute Disease; Adenosine; Aminohydrolases; Electrophoresis; Humans; Isoenzymes; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukocytes; Muramidase; Mycosis Fungoides; Phenotype | 1972 |
Symposium on Myocardial Blood Flow in Man--Methods and Significance in Myocardial Disease: Pisa, Italy; June 10-12, 1971. Report of the session on acute hypoxia.
Topics: Acute Disease; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Blood Flow Velocity; Calcium; Cardiac Output; Coronary Circulation; Coronary Disease; Dogs; Glycolysis; Guinea Pigs; Heart; Humans; Hydrogen-Ion Concentration; Hypoxia; Lipid Metabolism; Mitochondria, Muscle; Myocardium; Oxygen Consumption; Propranolol; Rabbits | 1972 |
Temperature conversion factors, activation energy, relative substrate specificity and optimum pH of adenosine deaminase from human serum and tissues.
Topics: Acute Disease; Adenosine; Aminohydrolases; Animals; Cattle; Deoxyadenosines; Duodenum; Enzyme Activation; Hepatitis A; Humans; Intestinal Mucosa; Intestines; Liver; Mathematics; Species Specificity; Structure-Activity Relationship; Temperature; Typhoid Fever | 1971 |